Jones Financial Companies Lllp Biotechnology

Jones Financial Companies Lllp

$97.4 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ARGX Argenx Se	$36.2B	$3,000 0.0% of portfolio	6	Q3 2024 New
NTRB Nutri Band Inc.	$64.7M	$3,000 0.0% of portfolio	500	Q2 2024 New
ABCL Ab Cellera Biologics Inc.	$904M	$2,000 0.0% of portfolio	925	Q3 2024 Reduced 71.81%
ACAD Acadia Pharmaceuticals Inc	$3.02B	$2,000 0.0% of portfolio	162	Q3 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$797M	$2,000 0.0% of portfolio	250	Q3 2024 New
RNA Avidity Biosciences, Inc.	$1.72B	$2,000 0.0% of portfolio	55	Q3 2024 New
BCYC Bicycle Therapeutics PLC	$397M	$2,000 0.0% of portfolio	100	Q2 2024 New
VERU Veru Inc.	$44.9M	$2,000 0.0% of portfolio	3,154	Q3 2024 New
ROIV Roivant Sciences Ltd.	$7.84B	$2,000 0.0% of portfolio	200	Q2 2024 New
AKBA Akebia Therapeutics, Inc.	$428M	$1,000 0.0% of portfolio	1,000	Q3 2024 New
AVXL Anavex Life Sciences Corp.	$723M	$1,000 0.0% of portfolio	200	Q2 2024 New
ARWR Arrowhead Pharmaceuticals, Inc.	$2.1B	$1,000 0.0% of portfolio	100	Q3 2024 New
BGNE Bei Gene, Ltd.	$23.5B	$1,000 0.0% of portfolio	5	Q3 2024 Reduced 54.55%
CLSD Clearside Biomedical, Inc.	$56M	$1,000 0.0% of portfolio	1,000	Q3 2024 New
MNKD Mannkind Corp	$1.49B	$1,000 0.0% of portfolio	194	Q3 2024 New
MIST Milestone Pharmaceuticals Inc.	$59.1M	$1,000 0.0% of portfolio	1,000	Q3 2024 Reduced 6.54%
ORMP Oramed Pharmaceuticals Inc.	$87M	$1,000 0.0% of portfolio	572	Q3 2024 New
PYXS Pyxis Oncology, Inc.	$56.9M	$1,000 0.0% of portfolio	500	Q2 2024 New
RARE Ultragenyx Pharmaceutical Inc.	$3.01B	$1,000 0.0% of portfolio	28	Q3 2024 Reduced 26.32%
AVTE Aerovate Therapeutics, Inc.	$64.1M	$0 0.0% of portfolio	100	Q2 2024 New
AMRN Amarin Corp Plcuk	$234M	$0 0.0% of portfolio	97	Q2 2024 New
AVIR Atea Pharmaceuticals, Inc.	$255M	$0 0.0% of portfolio	207	Q2 2024 New
ATHA Athira Pharma, Inc.	$18.9M	$0 0.0% of portfolio	334	Q3 2024 New
ICCC Immucell Corp	$41.3M	$0 0.0% of portfolio	19	Q2 2024 New
LUMO Lumos Pharma, Inc.	$36.4M	$0 0.0% of portfolio	4	Q2 2024 New
LYRA Lyra Therapeutics, Inc.	$6.05M	$0 0.0% of portfolio	500	Q3 2024 New
MRVI Maravai Lifesciences Holdings, Inc.	$648M	$0 0.0% of portfolio	11	Q3 2024 New
MRSN Mersana Therapeutics, Inc.	$59.3M	$0 0.0% of portfolio	200	Q3 2024 New
PMCB Pharma Cyte Biotech, Inc.	$33M	$0 0.0% of portfolio	2	Q3 2024 New
SAGE Sage Therapeutics, Inc.	$431M	$0 0.0% of portfolio	37	Q3 2024 Reduced 63.0%
SLS Sellas Life Sciences Group, Inc.	$33.3M	$0 0.0% of portfolio	374	Q2 2024 New
STOK Stoke Therapeutics, Inc.	$453M	$0 0.0% of portfolio	50	Q3 2024 New
SMMT Summit Therapeutics Inc.	$4.42B	$0 0.0% of portfolio	40	Q3 2024 New
VXRT Vaxart, Inc.	$86M	$0 0.0% of portfolio	123	Q3 2024 New
VRCA Verrica Pharmaceuticals Inc.	$327M	$0 0.0% of portfolio	73	Q3 2024 New
VIRX Viracta Therapeutics, Inc.	$5.63M	$0 0.0% of portfolio	1,000	Q3 2024 New
VYGR Voyager Therapeutics, Inc.	$214M	$0 0.0% of portfolio	155	Q2 2024 New
CVAC Cure Vac N.V.	$710M	$0 0.0% of portfolio	25	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.